Global team of scientists has developed a representation of human metabolism applicable to computational modeling.
Research partnership hopes to use novel proteomic MS techniques to provide a deeper understanding of disease mechanisms.
Bayer HealthCare calls forth pharmaceutical companies, small and medium enterprises and academics.
Stuart Meredith is announced as PharmaTimes magazine’s ‘Clinical Research Associate of the Year’.
Selventa announce development focus on a new class of diagnostic test for autoimmune disease and cancer
‘Multi-omic’ biomarker diagnostics will look to improve patient therapy selection.
Kinetic isotope effects do not bias doping control analysis, say researchers at the Doping Control Laboratory at the Olympic Athletic Center of Athens.
In a recent company press release, Bristol-Myers Squibb has announced the appointment of Mike Burgess as Senior Vice President of their Discovery Medicine and Clinical Pharmacology department.
Partnership of MPI Research, INVICRO and 3D Imaging is anticipated to speed up drug discovery with the establishment of a new site with both imaging and vivarium facilities.
This issue discusses the challenges faced in the development and validation of bioanalytical methods to assess biosimilar products.
Life Technologies had revenue of US$3.8 billion in 2012, and has over 10,000 employees worldwide.